Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-03-028400

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
SODERBERG PER OLOF Director 2003-10-29 Grant or award · Non-qualified Stock Option (right to buy) +25,000 25,000 D: show line 1 in the form
Loading xslF345X02/rrd21351.xml…